--> --> -->

Blogs

06
Feb 2024

Safeguarding Quality - Evaluating Container Closure Integrity in High-Risk Pharma

Safeguarding Quality - Evaluating Container Closure Integrity in High-Risk Pharma

High-risk pharmaceutical products refer to medications and substances that, due to their nature or intended use, pose a higher level of risk to patients and the public. These products often include injectable drugs, biologics, vaccines, and other sensitive formulations that require stringent quality control measures to ensure patient safety and regulatory compliance.

The packaging of high-risk pharmaceutical products presents unique challenges due to the need for exceptional product protection, stability, and, most importantly, containment of the product to prevent contamination. As these products are often administered directly into the body, maintaining the integrity of the container closure system is critical to prevent microbial ingress, oxygen exposure, and other factors that could compromise the drug's efficacy and safety.

Container Closure Integrity (CCI) testing is a vital process within the pharmaceutical industry to verify that the packaging of a product effectively prevents any leakage or contamination. This testing is crucial in ensuring that the pharmaceutical product maintains its integrity throughout its shelf life, safeguarding patient safety and therapeutic efficacy.

MicroCurrent HVLD Technolgy for Testing Integrity of High-Risk Pharma

PTI's MicroCurrent HVLD technology represents a non-destructive and non-invasive approach to testing the container closure integrity (CCI) of various liquid-filled products, including pre-filled syringes, vials, cartridges, ampoules, blow-fill-seal (BFS) containers, bottles, and pouches. This method has proven to be highly effective in ensuring the integrity of container closures in diverse applications.

The technology employs electrode probes to scan sealed containers, aiming to detect any potential leaks. By analyzing changes in the current flow, both the existence of defects in the container and their approximate locations can be identified with precision. This makes the MicroCurrent HVLD technology particularly versatile, capable of detecting leaks in a wide range of liquid-filled products, even those with extremely low conductivity, such as sterile water for injection (WFI) and proteinaceous products with suspensions.

One notable advantage of MicroCurrent HVLD is its efficiency in terms of voltage usage. It utilizes approximately 50% less voltage compared to conventional HVLD solutions, contributing to a more energy-efficient and environmentally friendly testing process. Moreover, the reduced voltage exposure (less than 5% compared to traditional methods) minimizes potential risks to both the product and the testing environment.

Benefits of MicroCurrent HVLD:

  • Deterministic, non-destructive, non-invasive, non-subjective
  • High level of repeatability and accuracy
  • Ideal package integrity solution for liquid filled parenteral products
  • Low voltage exposure to the product and environment
  • Offline and automated online inspection
  • Referenced in USP 1207 guideline
Readmore...
ccit, container closure integrity testing, hvld, microcurrent hvld, usp 1207, hvld technology
647

Popular Blogs

Tags

CCIT for Pharmaceutical Package Integrity

Jul 23, 2021   |   3031

Container Closure Integrity Testing of pharmaceutical packaging ensures that the products remain intact throughout its shelf life or until it reaches the end user.

Techniques Involved in Leak Testing Vials

Sep 06, 2022   |   2765

Most common methods for leak testing vials include MicroCurrent HVLD Technology, Helium Leak Testing and Vacuum Decay Technology.

Why is Seal Integrity Testing of Medical Device Packaging Important

Jul 29, 2021   |   2728

For sterile medical devices, seal integrity testing ensures product efficacy, shelf-life stability, and microbial sterility. Airborne Ultrasound technology is a non-destructive Container Closure Integrity test method, capable of examining seal quality for defects.

A Guide to MicroCurrent HVLD Technology

Aug 05, 2021   |   2667

In the case of parenteral drug product containers, HVLD technology is ideal for CCI testing in cases where packaging is less conductive than the liquid within.

Everything You Need to Know About Vacuum Decay Technology

Sep 09, 2022   |   2556

Vacuum Decay technology is the ideal non-destructive solution for container closure integrity determination for many package formats.
Popup